Approval · Notice of Compliance 69 · 2004
ARIXTRA: Notice of Compliance 69
Issued March 15, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 69
- Date
- March 15, 2004
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update the action and clinical pharmacology section of the product monograph with regards to extended prophylaxis of thromboembolic events in patients undergoing hip fracture surgery
- Therapeutic class
- Synthetic antithrombotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ARIXTRA | Not yet assigned | — |
Medicinal ingredients
- FONDAPARINUX SODIUM 2.5 MG per 0.5ML